Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
ZIM Integrated Shipping Services
ZIM
$3.57B
| $389K | ﹤0.01% |
24,174
-739
| -3% | -$11.6K |
2022 Q1
13 quarters
|
|
3827
Stratasys
SSYS
$762M
| $388K | ﹤0.01% |
33,862
| – | – |
2013 Q4
46 quarters
|
|
|
DOO
3828
Bombardier Recreational Products
DOO
$3.98B
| $388K | ﹤0.01% |
8,013
-1,266
| -14% | -$50K |
2022 Q1
13 quarters
|
|
3829
Lifecore Biomedical
LFCR
$248M
| $388K | ﹤0.01% |
47,775
+22,321
| +88% | +$150K |
2024 Q2
4 quarters
|
|
3830
Symbotic
SYM
$5.62B
| $387K | ﹤0.01% |
9,965
+951
| +11% | +$24.9K |
2022 Q3
11 quarters
|
|
3831
Monte Rosa Therapeutics
GLUE
$896M
| $387K | ﹤0.01% |
85,712
+39,502
| +85% | +$176K |
2022 Q1
13 quarters
|
|
3832
Skillsoft
SKIL
$52M
| $386K | ﹤0.01% |
24,200
+7,941
| +49% | +$150K |
2022 Q1
13 quarters
|
|
3833
ChargePoint
CHPT
$249M
| $386K | ﹤0.01% |
27,440
-18,090
| -40% | -$242K |
2022 Q1
13 quarters
|
|
3834
Five Point Holdings
FPH
$326M
| $385K | ﹤0.01% |
70,087
| – | – |
2017 Q2
32 quarters
|
|
3835
Baytex Energy
BTE
$3.24B
| $384K | ﹤0.01% |
214,550
-69,639
| -25% | -$122K |
2023 Q1
9 quarters
|
|
3836
SkinHealth Systems
SKIN
$82M
| $383K | ﹤0.01% |
200,512
+119,742
| +148% | +$169K |
2022 Q1
13 quarters
|
|
3837
CALL
Lumentum
LITE
$97.4B
| $380K | ﹤0.01% |
+4,000
| New | +$284K |
2025 Q2
0 quarters
|
|
3838
ARK Genomic Revolution ETF
ARKG
$2.32B
| $380K | ﹤0.01% |
15,601
-20,774
| -57% | -$455K |
2020 Q4
18 quarters
|
|
3839
SELLAS Life Sciences
SLS
$2.37B
| $378K | ﹤0.01% |
+172,803
| New | +$265K |
2025 Q2
0 quarters
|
|
3840
Expensify
EXFY
$205M
| $378K | ﹤0.01% |
146,015
-25,119
| -15% | -$64.2K |
2023 Q1
9 quarters
|
|
3841
Pure Cycle
PCYO
$263M
| $378K | ﹤0.01% |
35,256
+14,313
| +68% | +$148K |
2017 Q2
32 quarters
|
|
3842
Norwood Financial Corp
NWFL
$367M
| $377K | ﹤0.01% |
14,641
+6,245
| +74% | +$156K |
2022 Q3
11 quarters
|
|
|
SEPN
3843
Septerna Inc
SEPN
$1.76B
| $377K | ﹤0.01% |
35,706
+12,973
| +57% | +$107K |
2024 Q4
2 quarters
|
|
3844
Inspired Entertainment
INSE
$91.3M
| $377K | ﹤0.01% |
46,130
+21,020
| +84% | +$163K |
2022 Q2
12 quarters
|
|
3845
PCB Bancorp
PCB
$393M
| $376K | ﹤0.01% |
17,922
+7,012
| +64% | +$136K |
2022 Q2
12 quarters
|
|
3846
Paymentus
PAY
$3.88B
| $375K | ﹤0.01% |
11,453
+5,838
| +104% | +$195K |
2023 Q2
8 quarters
|
|
3847
Omeros
OMER
$1.35B
| $374K | ﹤0.01% |
124,831
+43,490
| +53% | +$217K |
2013 Q2
48 quarters
|
|
3848
Anika Therapeutics
ANIK
$256M
| $374K | ﹤0.01% |
35,390
+7,379
| +26% | +$93.1K |
2013 Q2
48 quarters
|
|
|
ESSA
3849
DELISTED
ESSA Bancorp
ESSA
| $374K | ﹤0.01% |
19,268
+4,702
| +32% | +$86.9K |
2017 Q1
33 quarters
|
|
3850
NACCO Industries
NC
$274M
| $373K | ﹤0.01% |
8,414
+2,665
| +46% | +$96.6K |
2022 Q2
12 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.